http://orcid.org/0000-0003-0432-2624
References
- Le Mao R, Tromeur C, Paleiron N, et al. Effect of early initiation of varenicline on smoking cessation in COPD patients admitted for exacerbation: the save randomized clinical trial. COPD 2020;17(1):7–14.
- Tashkin DP, Rennard S, Hays JT, et al. Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. Chest. 2011;139(3):591–599.
- Schwartz J, Fadahunsi O, Hingorani R, et al. Use of varenicline in smokeless tobacco cessation: a systematic review and meta-analysis. Nicotine Tob Res. 2016;18(1):10–16. doi:10.1093/ntr/ntv010.
- Smith BJ, Carson KV, Brinn MP, et al. Smoking Termination Opportunity for in Patients (STOP): superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: a 12-month randomised controlled trial for inpatients. Thorax 2013;68(5):485–486. doi:10.1136/thoraxjnl-2012-202484.
- Hajek P, Tonnesen P, Arteaga C, et al. Varenicline in prevention of relapse to smoking: Effect of quit pattern on response to extended treatment. Addiction. 2009;104(9):1597–1602. doi:10.1111/j.1360-0443.2009.02646.x.
- Williams KE, Reeves KR, Billing CB Jr, et al. A double-blind study evaluating the long-term safety of varenicline for smoking cessation. Curr Med Res Opin. 2007;23(4):793–801.